Description
In this video, our speakers offer insights from both healthcare providers and patient advocates, highlighting key strategies to improve collaboration between patients and providers. They focus on enhancing understanding of rare liver diseases and promoting greater concordance with prescribed treatment plans, emphasizing the importance of patient engagement, clear communication, and shared decision-making to achieve better health outcomes.
The EASL Policy Dialogues Season 3 is supported by Novo Nordisk. EASL has received no input from Novo Nordisk with regards to the content of the EASL Policy Dialogues Season 3.